The purpose of the study is to evaluate the safety and efficacy of a fixed-dose combination drug compared to two other drugs (monotherapies) in controlling hypertension.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
837
PERa/AMLb capsule taken once daily by mouth for six weeks
AMLb capsule taken once daily by mouth for six weeks
PERe capsule taken once daily by mouth for six weeks
Change From Baseline to End of Treatment in the Mean Seated Trough Cuff Diastolic Blood Pressure (DBP).
Time frame: Day 0 to Day 42
Change From Baseline to End of Treatment in the Mean Seated Trough Cuff Systolic Blood Pressure (SBP).
Time frame: Day 0 to Day 42
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Huntsville, Alabama, United States
Unnamed facility
Muscle Shoals, Alabama, United States
Unnamed facility
Glendale, Arizona, United States
Unnamed facility
Greenbrae, California, United States
Unnamed facility
Los Angeles, California, United States
Unnamed facility
Santa Ana, California, United States
Unnamed facility
Denver, Colorado, United States
Unnamed facility
DeLand, Florida, United States
Unnamed facility
Fort Lauderdale, Florida, United States
Unnamed facility
Miami, Florida, United States
...and 38 more locations